OTC Analgesic Toxicity Review Expected By Fall – FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA plans to review the potential toxicity risks of all OTC analgesics at an upcoming advisory committee meeting, the agency said
You may also be interested in...
OTC Analgesic Additional Safety Labeling To Be Considered By NDAC
Possible new labeling requirements and other initiatives designed to ensure the safety of OTC analgesics will be considered by FDA's Nonprescription Drugs Advisory Committee at a Sept. 19-20 meeting in Silver Spring, Md
OTC Analgesic Additional Safety Labeling To Be Considered By NDAC
Possible new labeling requirements and other initiatives designed to ensure the safety of OTC analgesics will be considered by FDA's Nonprescription Drugs Advisory Committee at a Sept. 19-20 meeting in Silver Spring, Md
OTC Analgesic Additional Safety Labeling To Be Considered By NDAC
Possible new labeling requirements and other initiatives designed to ensure the safety of OTC analgesics will be considered by FDA's Nonprescription Drugs Advisory Committee at a Sept. 19-20 meeting in Silver Spring, Md